Want to see JP:6407 full AI Analyst Report?
6407 Stock Chart & Stats
¥5540.00
-¥76.00(-2.88%)
At close: 4:00 PM EST
¥5540.00
-¥76.00(-2.88%)
Day’s Range― - ―
52-Week Range¥2,451.00 - ¥8,330.00
Previous CloseN/A
Volume278.00K
Average Volume (3M)934.41K
Market Cap
¥319.66B
Enterprise Value¥490.00B
Total Cash (Recent Filing)¥42.49B
Total Debt (Recent Filing)¥33.24B
Price to Earnings (P/E)18.7
Beta1.77
Next Earnings
Nov 13, 2026EPS Estimate
74.07Next Dividend Ex-DateN/A
Dividend Yield2.03%
Share Statistics
EPS (TTM)251.22
Shares Outstanding68,279,450
10 Day Avg. Volume1,770,420
30 Day Avg. Volume934,410
Financial Highlights & Ratios
PEG Ratio57.49
Price to Book (P/B)1.86
Price to Sales (P/S)1.81
P/FCF Ratio23.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥7,308.57Price Target Upside31.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)335.27
Revenue Forecast (FY)¥205.22B
Bulls Say, Bears Say
Bulls Say
Solid ProfitabilitySustained gross and operating margins indicate that CKD’s automation and fluid-control products retain meaningful economic value across industrial customers. This profitability provides resources for product development, customer support, and investment while offering resilience through normal manufacturing cycles.
Conservative LeverageLow leverage gives CKD financial flexibility to fund growth, maintain operations during weaker factory-investment cycles, and absorb moderate earnings pressure without excessive refinancing dependence. Growing equity further strengthens the balance sheet and supports durable strategic investment capacity.
Recent Earnings RecoveryThe return to revenue growth alongside stronger earnings suggests improving demand and operating leverage after a weaker period. If sustained, this recovery can reinforce CKD’s customer relationships, expand its installed base, and improve the company’s ability to reinvest in automation offerings.
Bears Say
Volatile Free Cash FlowRecent positive free cash flow is encouraging, but the prior sharp swings show that accounting profits do not consistently translate into cash generation. This volatility can constrain the timing of investment, shareholder returns, and balance-sheet strengthening when operating conditions weaken.
Uneven Revenue TrajectoryAn uneven sales trajectory indicates that CKD remains exposed to changing industrial demand and customer investment patterns. A renewed growth phase is constructive, but another contraction could reduce utilization, pressure margins, and make earnings less predictable over the next several quarters.
Higher Debt Than Prior YearsThe increase in total debt introduces more fixed financial obligations than CKD carried in earlier years. Even with conservative leverage overall, higher borrowings can reduce flexibility if cash flow again becomes volatile or if the company needs to fund expansion during a weaker demand cycle.
CKD Corporation News
6407 FAQ
What was CKD Corporation’s price range in the past 12 months?
CKD Corporation lowest stock price was ¥2451.00 and its highest was ¥8330.00 in the past 12 months.
What is CKD Corporation’s market cap?
CKD Corporation’s market cap is ¥319.66B.
When is CKD Corporation’s upcoming earnings report date?
CKD Corporation’s upcoming earnings report date is Nov 13, 2026 which is in 15 days.
How were CKD Corporation’s earnings last quarter?
CKD Corporation released its earnings results on Aug 10, 2026. The company reported ¥85.09 earnings per share for the quarter, beating the consensus estimate of ¥66.009 by ¥19.081.
Is CKD Corporation overvalued?
According to Wall Street analysts CKD Corporation’s price is currently Undervalued.
Does CKD Corporation pay dividends?
CKD Corporation pays a Semiannually dividend of ¥48 which represents an annual dividend yield of 2.03%. See more information on CKD Corporation dividends here
What is CKD Corporation’s EPS estimate?
CKD Corporation’s EPS estimate is 74.07.
How many shares outstanding does CKD Corporation have?
CKD Corporation has 68,279,450 shares outstanding.
What happened to CKD Corporation’s price movement after its last earnings report?
CKD Corporation reported an EPS of ¥85.09 in its last earnings report, beating expectations of ¥66.009. Following the earnings report the stock price went down -4.739%.
Which hedge fund is a major shareholder of CKD Corporation?
Currently, no hedge funds are holding shares in JP:6407
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CKD Corporation
CKD Corporation is a global provider engaged in the design, manufacturing, sale, and export of industrial automation equipment and various components. The company operates through its Automatic Machinery and Component Products segments. Its extensive product range includes sophisticated packaging machines for the medical, pharmaceutical, and food sectors, alongside industrial machinery such as lithium-ion battery winding systems and solder paste inspection devices, as well as lamp-related equipment. CKD also offers labor-saving components like index units, direct drive motors, and pick-and-place units. Additionally, it supplies pneumatic control components, including directional control valves, and drive components such as pneumatic cylinders, auxiliary devices, and hand chucks. The company further provides fine system components and fluid control solutions, which comprise specialized valves and unit systems designed for managing and processing fluids. Established in 1943, the firm was formerly called Chukyo Electric Co., Ltd. until its rebranding to CKD Corporation in July 1979. Its headquarters are situated in Komaki, Japan.
6407 Stock 12 Month Forecast
Average Price Target
¥7,308.57
▲(31.92% Upside)
Technical Analysis
Harmonic Drive Systems
―
Nabtesco
―
THK Co
―
ANEST IWATA Corp.
―
Daihen Corporation
―




